Literature DB >> 9673969

[Neuroradiologic diagnosis in acute arterial cerebral infarct. Current status of new methods].

O Jansen1, S Heiland, P Schellinger.   

Abstract

At least three questions has to be answered by imaging methods, when new therapies in acute ischemic stroke should be used: 1. Is there a cerebral ischemia? 2. What is the size of the irreversible damaged tissue and what is the size of the safeable tissue? Is there still a vessel occlusion? New MRI-techniques including MR-angiography, diffusion-weighted imaging and perfusion-MRI, have the potential to describe the status of the brain in detail and to answer these questions. However, the value of these techniques for therapeutical decisions (thrombolysis) is unclear and has to be evaluated in clinical studies. Therefore in clinical routine these decisions should still be based on informations from CT and perhaps CT-angiography.

Entities:  

Mesh:

Year:  1998        PMID: 9673969     DOI: 10.1007/s001150050299

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  4 in total

1.  MRI of blood-brain barrier permeability in cerebral ischemia.

Authors:  Quan Jiang; James R Ewing; Michael Chopp
Journal:  Transl Stroke Res       Date:  2012-03       Impact factor: 6.829

Review 2.  Intracranial hemorrhage: the role of magnetic resonance imaging.

Authors:  Peter D Schellinger; Jochen B Fiebach
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

3.  Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia.

Authors:  P D Schellinger; O Jansen; J B Fiebach; O Pohlers; H Ryssel; S Heiland; T Steiner; W Hacke; K Sartor
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

4.  Contrast-enhanced magnetic resonance angiography in stroke diagnostics: additional information compared with time-of-flight magnetic resonance angiography?

Authors:  K Alfke; U Jensen; C Pool; A Rohr; R Brüning; J Weber; T Bartsch; R Stingele; O Jansen
Journal:  Clin Neuroradiol       Date:  2010-11-26       Impact factor: 3.649

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.